Editas Medicine, Inc.

NasdaqGS:EDIT Stock Report

Mkt Cap: US$700.2m

Editas Medicine Financial Health

How is Editas Medicine's financial position?

Financial Health Score

6/6

Financial Health Score 6/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Stable Cash Runway

  • Forecast Cash Runway

Financial Position Analysis

Short Term Liabilities: EDIT's short term assets ($426.6M) exceed its short term liabilities ($42.3M).

Long Term Liabilities: EDIT's short term assets ($426.6M) exceed its long term liabilities ($74.0M).


Debt to Equity History and Analysis

Debt Level: EDIT is debt free.

Reducing Debt: EDIT had no debt 5 years ago.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: EDIT has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: EDIT has sufficient cash runway for 1.9 years if free cash flow continues to reduce at historical rates of 32.6% each year.


Discover healthy companies